With unprecedented speed, pharmaceutical giants rose to the occasion and developed the vaccines essential to combat – and hopefully end – the COVID-19 pandemic. And while the creation of these vaccines marked incredible progress, it is just the first step in what will be a months-long effort to get enough shots in arms in order to reach herd immunity in the United States.
As those administering the vaccines grapple with multiple moving parts, competing priorities, and the race against emerging virus variants; the need to capture, manage, and optimize inoculation data has come into sharp focus.
Download our latest white paper to explore: